Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/7156

Propyl gallate: Target Organs and Levels of Evidence for TR-240

Carcinogenesis Bioassay of Propyl Gallate (CASRN 121-79-9) in F344/N Rats and B6C3F1 Mice (Feed Study)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
Propyl gallate
121-79-9
12/16/1981Dosed-Feed
0,6000,12000 PPM/50 PER GROUP
Southern Research Institute

Levels of Evidence

Male Rats: Equivocal
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Preputial Gland: ADENOMA 0/50 5/50 0/50; ADENOMA, ADENOCARCINOMA 0/50 3/50 0/50, OR CARCINOMA 1/50 0/50 0/50 COMBINED 1/50 8/50 0/50
  • Pancreas Islet Cell: ADENOMA 0/50 8/50 2/50 ADENOMA OR CARCINOMA 2/50 1/50 2/50 COMBINED 2/50 9/50 4/50
  • Adrenal Gland Medulla: PHEOCHROMOCYTOMA 4/50 13/48 8/50
Female Rats: Negative
Male Mice: Equivocal
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Hematopoietic System: LYMPHOMA 1/50 3/49 8/50
Female Mice: Negative